日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multi-center evaluation of the first, low-cost, open source and totally 3D-printed pediatric laparoscopic trainer

首个低成本、开源且完全3D打印的儿科腹腔镜训练器的多中心评估

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e40550
Lubet, Alexis; Renaux-Petel, Mariette; Marret, Jean-Baptiste; Rod, Julien; Sibert, Louis; Delbreilh, Laurent; Liard, Agnès
3D/类器官
发表日期：2024
文献求助 收藏

Conception and validation of A 3d printed learning model of supra condylar fracture of children

儿童股骨髁上骨折3D打印学习模型的构思与验证

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e30741
Lubet, Alexis; Renaux-Petel, Mariette; Delbreilh, Laurent; Liard-Zmuda, Agnès; Auble, Annabelle; Payen, Mathilde
3D/类器官
骨折
发表日期：2024
文献求助 收藏

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention

针对TOP2A的疫苗在三阴性乳腺癌免疫预防方面表现出显著疗效

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-023-00461-1
Lee, Sang Beom; Pan, Jing; Xiong, Donghai; Palen, Katie; Johnson, Bryon; Lubet, Ronald A; Shoemaker, Robert H; Green, Jeffrey E; Fernando, Romaine Ingrid; Sei, Shizuko; You, Ming; Wang, Yian
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

酪氨酸激酶抑制剂在临床预防/拦截研究中应用的主要障碍：EGFR抑制剂的临床前研究是否为克服某些局限性提供了思路？

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2023.1170444
Dragnev, Konstantin H; Dragnev, Christo P C; Lubet, Ronald A
信号转导
EGFR
EGF
发表日期：2023
文献求助 收藏

COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes

COX-2抑制剂降低结肠肿瘤中PD-L1的表达并增加I型肿瘤浸润淋巴细胞的流入

期刊:Cancer Prevention Research
影响因子:2.6
doi:10.1158/1940-6207.CAPR-21-0227
Cecil, Denise L; Gad, Ekram A; Corulli, Lauren R; Drovetto, Nicholas; Lubet, Ronald A; Disis, Mary L
PD-L1
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer

靶向谷氨酰胺代谢以增强 EGFR 驱动的肺癌的免疫预防

期刊:Advanced Science
影响因子:
doi:10.1002/advs.202105885
Mofei Huang, Donghai Xiong, Jing Pan, Qi Zhang, Shizuko Sei, Robert H Shoemaker, Ronald A Lubet, Luis M Montuenga, Yian Wang, Barbara S Slusher, Ming You
代谢
肿瘤
肺癌
Cell sorting
FCM
Mouse
IL-17
发表日期：2022
文献求助 收藏

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention.

用于结肠癌治疗和预防的多表位疫苗

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.729809
Corulli Lauren R, Cecil Denise L, Gad Ekram, Koehnlein Marlese, Coveler Andrew L, Childs Jennifer S, Lubet Ronald A, Disis Mary L
肿瘤
肠癌
发表日期：2021
文献求助 收藏

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

针对免疫检查点蛋白 VISTA 的小分子 CA170 抑制肺癌发生

期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-021-02381-x
Jing Pan #, Yao Chen #, Qi Zhang #, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D Johnson, Charles R Myers, Shizuko Sei, Robert H Shoemaker, Ronald A Lubet, Yian Wang, Weiguo Cui, Ming You
信号转导
肿瘤
肺癌
Cell Depletion
WB
Checkpoint
Mouse
CD8A
发表日期：2021
文献求助 收藏

Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers

采用脉冲式或间歇式给药的厄洛替尼和萘普生联合用药可显著抑制膀胱癌。

期刊:Cancer Prevention Research
影响因子:2.6
doi:10.1158/1940-6207.CAPR-19-0339
Mohammed, Altaf; Miller, Mark Steven; Lubet, Ronald A; Suen, Chen S; Sei, Shizuko; Shoemaker, Robert H; Juliana, Margaret M; Moeinpour, Fariba L; Grubbs, Clinton J
肿瘤
肿瘤免疫
膀胱癌
发表日期：2020
文献求助 收藏

Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced Cancers

利用正常乳腺上皮细胞生物标志物调控作为化学预防剂对抗化学诱发癌症疗效的相关性

期刊:Cancer Prevention Research
影响因子:2.6
doi:10.1158/1940-6207.CAPR-19-0318
Lubet, Ronald A; Heckman-Stoddard, Brandy M; Fox, Jennifer T; Moeinpour, Fariba; Juliana, M Margaret; Shoemaker, Robert H; Grubbs, Clinton J
肿瘤
肿瘤免疫
上皮细胞
信号转导
细胞生物学
发表日期：2020
文献求助 收藏